MEPs And Health Advocates Pile The Pressure On EU Drug Pricing
Executive Summary
A European Parliament committee has approved a report outlining some possible solutions to the question of access to expensive new drugs, while Health Action International and several other NGOs have put emphasis on the need to ensure that where drugs developed by private companies use publicly funded research, they really serve the public good.